Free Trial

CANADA LIFE ASSURANCE Co Sells 3,798 Shares of Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

CANADA LIFE ASSURANCE Co trimmed its holdings in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 8.5% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 40,875 shares of the business services provider's stock after selling 3,798 shares during the quarter. CANADA LIFE ASSURANCE Co owned about 0.08% of Exponent worth $3,637,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. Private Trust Co. NA grew its holdings in shares of Exponent by 129.8% in the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock worth $25,000 after acquiring an additional 157 shares during the period. Atala Financial Inc purchased a new position in Exponent in the fourth quarter worth about $25,000. Westside Investment Management Inc. bought a new stake in shares of Exponent during the 3rd quarter valued at about $26,000. Tortoise Investment Management LLC increased its position in shares of Exponent by 76.7% during the 4th quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after purchasing an additional 191 shares during the last quarter. Finally, Trust Co. of Vermont bought a new position in shares of Exponent in the 4th quarter worth approximately $45,000. Hedge funds and other institutional investors own 92.37% of the company's stock.

Exponent Price Performance

Shares of EXPO traded down $0.28 on Thursday, reaching $78.40. The company's stock had a trading volume of 57,453 shares, compared to its average volume of 239,177. Exponent, Inc. has a 12-month low of $73.83 and a 12-month high of $115.75. The stock has a market capitalization of $3.98 billion, a P/E ratio of 37.01 and a beta of 0.84. The stock's 50 day simple moving average is $80.92 and its two-hundred day simple moving average is $90.34.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter in the previous year, the firm posted $0.41 EPS. Analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current year.

Insider Activity at Exponent

In other news, VP Richard Reiss sold 1,736 shares of the firm's stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the transaction, the vice president now owns 1,800 shares of the company's stock, valued at $154,674. This trade represents a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.10% of the stock is owned by company insiders.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines